The fintech is funding a buyback with debt instead of cash, and the structure behind it says more than the headline number.

Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) (“Ligand”) announced today the pricing of $625.0 million aggregate principal amount of 0.0% convertible senior notes due 2031 (the “notes”) in a ...

Learn how senior notes work as secure bond investments, their priority in bankruptcy, and the benefits and risks involved for ...

Robinhood Markets said it intends to offer $2 billion of convertible senior notes due 2029 in a private placement. The financial services company said it intends to grant the initial purchasers of the ...

Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) (“Ligand”) announced today its intention to offer $550.0 million aggregate principal amount of convertible senior notes due 2031 (the “notes”) in a ...

Robinhood shares were up more than 1% during early morning trade, while the company said a portion of the proceeds will be ...

IREN closed a $3.0 billion convertible notes deal on Wednesday after the offering grew from an initial $2 billion proposal earlier in the week.

Robinhood Markets announces a private offering of convertible senior notes due 2029.

Learn about convertible securities, their types, features, and benefits, and understand conversion processes of bonds and ...

Repurchased $225 million principal amount of convertible notes removing approximately 8.3 million underlying shares as well as approximately $63.8 million of remaining interest Issued 9.45 million ...

The Notes will be redeemed on June 25, 2026 (the “Redemption Date”), at a price equal to 100% of their principal amounts, plus accrued but unpaid interest (the “Redemption Price”), in accordance with ...

At times, the founders fail to appreciate that a US-form SAFE (Simple Agreement for Future Equity) is not legally recognized in India and can lead to violation ...